Ayse Batova

1.2k total citations
28 papers, 995 citations indexed

About

Ayse Batova is a scholar working on Molecular Biology, Cancer Research and Plant Science. According to data from OpenAlex, Ayse Batova has authored 28 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Plant Science. Recurrent topics in Ayse Batova's work include Natural Compound Pharmacology Studies (7 papers), Neuroblastoma Research and Treatments (6 papers) and Retinoids in leukemia and cellular processes (6 papers). Ayse Batova is often cited by papers focused on Natural Compound Pharmacology Studies (7 papers), Neuroblastoma Research and Treatments (6 papers) and Retinoids in leukemia and cellular processes (6 papers). Ayse Batova collaborates with scholars based in United States, Taiwan and Thailand. Ayse Batova's co-authors include Alice L. Yu, Mitchell B. Diccianni, Emmanuel A. Theodorakis, Oraphin Chantarasriwong, John Yu, Warinthorn Chavasiri, Kim E. Creek, Lucia Pirisi, Jeanette Pullen and Tsutomu Nobori and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Ayse Batova

28 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayse Batova United States 18 603 232 174 173 157 28 995
Trevor Johnson United States 13 1.1k 1.8× 484 2.1× 116 0.7× 58 0.3× 170 1.1× 18 1.5k
Smita Matkar United States 12 549 0.9× 257 1.1× 92 0.5× 128 0.7× 23 0.1× 16 871
Takao Fujisawa Japan 13 861 1.4× 119 0.5× 56 0.3× 102 0.6× 28 0.2× 27 1.1k
Nengming Lin China 19 569 0.9× 221 1.0× 173 1.0× 22 0.1× 37 0.2× 55 870
Kang-Shen Yao United States 16 648 1.1× 212 0.9× 225 1.3× 18 0.1× 47 0.3× 23 937
Nabil Saleh United States 12 252 0.4× 255 1.1× 121 0.7× 18 0.1× 67 0.4× 29 756
Theoni Trangas Greece 19 717 1.2× 299 1.3× 318 1.8× 17 0.1× 38 0.2× 52 1.2k
Gilles Despouy France 16 838 1.4× 225 1.0× 276 1.6× 23 0.1× 43 0.3× 21 1.3k
Sumeer Dhar Sweden 17 450 0.7× 273 1.2× 85 0.5× 23 0.1× 26 0.2× 28 780
Alice Hlobílková Czechia 15 576 1.0× 252 1.1× 170 1.0× 16 0.1× 26 0.2× 26 889

Countries citing papers authored by Ayse Batova

Since Specialization
Citations

This map shows the geographic impact of Ayse Batova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayse Batova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayse Batova more than expected).

Fields of papers citing papers by Ayse Batova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayse Batova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayse Batova. The network helps show where Ayse Batova may publish in the future.

Co-authorship network of co-authors of Ayse Batova

This figure shows the co-authorship network connecting the top 25 collaborators of Ayse Batova. A scholar is included among the top collaborators of Ayse Batova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayse Batova. Ayse Batova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Alice L., Andrew L. Gilman, M. Fevzi Özkaynak, et al.. (2021). Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032. Clinical Cancer Research. 27(8). 2179–2189. 132 indexed citations
2.
Barnhill, Lisa M., Richard T. Williams, Ayse Batova, et al.. (2014). High Expression of CAI2 , a 9p21 -Embedded Long Noncoding RNA, Contributes to Advanced-Stage Neuroblastoma. Cancer Research. 74(14). 3753–3763. 39 indexed citations
3.
Williams, R. T., Lisa M. Barnhill, Huan-Hsien Kuo, et al.. (2014). Chimeras of p14ARF and p16: Functional Hybrids with the Ability to Arrest Growth. PLoS ONE. 9(2). e88219–e88219. 10 indexed citations
4.
Guizzunti, Gianni, Maria A. Theodoraki, Jing Xu, et al.. (2013). A-ring oxygenation modulates the chemistry and bioactivity of caged Garcinia xanthones. Organic & Biomolecular Chemistry. 11(20). 3341–3341. 16 indexed citations
5.
Williams, R. T., Alice L. Yu, Mitchell B. Diccianni, Emmanuel A. Theodorakis, & Ayse Batova. (2013). Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy. Journal of Experimental & Clinical Cancer Research. 32(1). 57–57. 34 indexed citations
6.
Xu, Jing, et al.. (2012). Formal Synthesis of (−)‐Englerin A and Cytotoxicity Studies of Truncated Englerins. Chemistry - An Asian Journal. 7(5). 1052–1060. 27 indexed citations
7.
Guizzunti, Gianni, Ayse Batova, Oraphin Chantarasriwong, Marianna Dakanali, & Emmanuel A. Theodorakis. (2012). Subcellular Localization and Activity of Gambogic Acid. ChemBioChem. 13(8). 1191–1198. 19 indexed citations
8.
Guizzunti, Gianni, Emmanuel A. Theodorakis, Alice L. Yu, Chiara Zurzolo, & Ayse Batova. (2011). Cluvenone induces apoptosis via a direct target in mitochondria: a possible mechanism to circumvent chemo-resistance?. Investigational New Drugs. 30(5). 1841–1848. 16 indexed citations
9.
Chantarasriwong, Oraphin, Ayse Batova, Warinthorn Chavasiri, & Emmanuel A. Theodorakis. (2010). Chemistry and Biology of the Caged Garcinia Xanthones. Chemistry - A European Journal. 16(33). 9944–9962. 111 indexed citations
10.
Batova, Ayse, Diego Altomare, Oraphin Chantarasriwong, et al.. (2010). The Synthetic Caged Garcinia Xanthone Cluvenone Induces Cell Stress and Apoptosis and Has Immune Modulatory Activity. Molecular Cancer Therapeutics. 9(11). 2869–2878. 22 indexed citations
11.
Chantarasriwong, Oraphin, Woo Cheal Cho, Ayse Batova, et al.. (2009). Evaluation of the pharmacophoric motif of the caged Garcinia xanthones. Organic & Biomolecular Chemistry. 7(23). 4886–4886. 52 indexed citations
12.
Batova, Ayse, Thanh Lam, Veit Wascholowski, et al.. (2006). Synthesis and evaluation of caged Garcinia xanthones. Organic & Biomolecular Chemistry. 5(3). 494–500. 36 indexed citations
13.
Yu, Alice L., et al.. (2004). Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma. Genes Chromosomes and Cancer. 41(4). 297–308. 12 indexed citations
15.
Diccianni, Mitchell B., et al.. (1999). Frequent deregulation ofp16 and thep16/G1 cell cycle-regulatory pathway in neuroblastoma. International Journal of Cancer. 80(1). 145–154. 33 indexed citations
16.
Diccianni, Mitchell B., Ayse Batova, John Yu, et al.. (1997). Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions. Leukemia Research. 21(6). 549–558. 33 indexed citations
17.
Diccianni, Mitchell B., et al.. (1996). The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance. Cancer Letters. 104(2). 183–192. 22 indexed citations
19.
Khan, Mohammad Afsar, et al.. (1994). Retinoic Acid Suppresses Human Papillomavirus Type 16 (HPV16)-Mediated Transformation of Human Keratinocytes and Inhibits the Expression of the HPV16 Oncogenes. Advances in experimental medicine and biology. 354. 19–35. 15 indexed citations
20.
Morré, D. James, Dorothy M. Morré, Mark Paulik, et al.. (1992). Retinoic acid and calcitriol inhibition of growth and NADH oxidase of normal and immortalized human keratinocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1134(3). 217–222. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026